With chimeric antigen receptor T-cell (CAR T) therapy, patients’ own immune cells can be “souped up” and used as a cancer treatment. This immunotherapy and its variants are a promising area of research, with fascinating safety considerations. Listen now to learn about CAR T and TCR T from Sanne Holt, a biologist at Charles River.